This study suggested that further screening of patients with drug-resistant ovarian cancer and those with platinum-sensitive ovarian cancer after sequencing may reveal an association between GPAT4 expression and platinum resistance in ovarian cancer. Here, GPAT4 is linked to ovarian cancer.